# Effect of TXA on Reducing Bruising After Filler Injection

> **NCT06665594** · PHASE2 · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 40 (estimated)

## Conditions studied

- Facial Filler Injections
- Hyaluronic Acid
- Tranexamic Acid

## Interventions

- **PROCEDURE:** Hyaluronic Acid (HA)
- **DRUG:** Tranexamic Acid (TXA)
- **DRUG:** Saline (placebo)

## Key facts

- **NCT ID:** NCT06665594
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665594, "Effect of TXA on Reducing Bruising After Filler Injection". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06665594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*